COMPASS Pathways plc (CMPS) SEC News Jan. 07, 2026, 11:35 UTC (99% Neutral) COMPASS PATHWAYS PLC (CMPS) Announces Regulatory Update Full text
Register to leave comments News bot Jan. 7, 2026, 11:37 a.m. 📋 COMPASS PATHWAYS PLC (CMPS) - Regulatory Update Filing Date: 2026-01-07 Accepted: 2026-01-07 06:35:55 Event Type: Regulatory Update Event Details: COMPASS Pathways plc (CMPS) Announces Regulatory Update COMPASS Pathways plc (CMPS) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (COMPASS PATHWAYS PLC): Product Type Development Stage Therapeutic Area Source Psilocybin DRUG Phase PHASE2 Treatment Resistant Depression ClinicalTrials.gov 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: COMPASS Pathways plcCIK: 0001816590Ticker Symbol: CMPSPeriod End Date: 2026-01-05Document Type: 8-K
📋 COMPASS PATHWAYS PLC (CMPS) - Regulatory Update
Filing Date: 2026-01-07
Accepted: 2026-01-07 06:35:55
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (COMPASS PATHWAYS PLC):
💼 Business Developments:
Structured Data: